Individuals heterozygous for germline loss-of-function (LoF) pathogenic variants in either of the MMR genes MLH1, MSH2, MSH6 or PMS2 have Lynch syndrome (LS), an autosomal dominant predisposition mainly to colorectal cancer and endometrial cancer (for a recent review of LS, see16). The gene discussed is MSH2; the disease is Lynch syndrome.